China Natural Investment Co Ltd ($8250) - buy or sell? Stock discussion, ideas, forum

China Natural Investment Co Ltd

China Natural Investment Company Ltd., through its subsidiaries, researches and develops testing services relating to the diagnosis of cancerous, prenatal, and other major diseases.

Industry: Healthcare-Services

Ticker	Exchange	ISIN	Name
$8250	HKEx GEM	KYG2113C1069	Code: 8250

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 8250 stock

Share your investment idea or question on China Natural Investment Co Ltd stock:

Latest twits on China Natural Investment Co Ltd (8250)

No twits yet. Be the first to post!

Have a question about 8250? Ask and other investors will be eager to help you.

Have an idea about 8250? Share it with other investors.

China Natural Investment Co Ltd news

25/09/2020 China Natural Investment Co Ltd reports 680% EBITDA decline in 2020 and 16.2% Revenue decline

27/09/2016 China Natural Investment Co Ltd reports 4,159% CAPEX growth in 2016 and 11.6% Revenue growth

24/09/2015 China Natural Investment Co Ltd revenue surged on 21.9% in 2015 while EBITDA Margin decreased on 2.5 pp from -7.2% to -9.6%

China Natural Investment Co Ltd stock price chart

China Natural Investment Co Ltd financials

mln.	FY2010	FY2011	FY2012

Revenue	4.704	41.903	51.252
EBITDA	-24.814	-10.434	-17.089
Net income	-1.456	-1.907	-16.181
CAPEX	61.181	82.836	18.850
Debt	0.000	0.000	0.000
Cash	42.973	68.900	32.847

China Natural Investment Co Ltd news

About China Natural Investment Co Ltd

China Natural Investment Company Ltd., through its subsidiaries, researches and develops testing services relating to the diagnosis of cancerous, prenatal, and other major diseases. The Company also retails health foods.